Skip to main content
ABBOTT LABORATORIES logo

ABBOTT LABORATORIES — Investor Relations & Filings

Ticker · ABT ISIN · US0028241000 LEI · HQD377W2YR662HK5JX27 US Manufacturing
Filings indexed 4,256 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country US United States of America
Listing US ABT

About ABBOTT LABORATORIES

https://www.abbott.com

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.

Recent filings

Filing Released Lang Actions
FORM SD
Regulatory Filings Classification · 92% confidence The document is a Form SD (Specialized Disclosure Report) filed under SEC Rule 13p-1 regarding conflict minerals. It is a standalone regulatory compliance filing, not an annual report, earnings release, or other specific category. There is no category for Form SD or conflict minerals, so it falls under the fallback “Regulatory Filings” category (RNS).
2026-05-27 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-29 English
10-Q
Interim / Quarterly Report
2026-04-29 English
FORM 8-K
Regulatory Filings
2026-04-27 English
S-8 - ABBOTT LABORATORIES (0000001800) (Filer)
Regulatory Filings
2026-04-24 English
8-K - ABBOTT LABORATORIES (0000001800) (Filer)
Legal Proceedings Report Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 10, 2026, by Abbott Laboratories. It reports on a legal proceeding related to shareholder derivative lawsuits and the court's preliminary approval of a proposed settlement. The document includes a notice of the proposed settlement as an exhibit. There are no financial statements or detailed financial data presented. The content focuses on legal proceedings and updates related to litigation, not on financial results, management changes, or other report types. Therefore, the document fits the category of Legal Proceedings Report (LTR). The document length is 4172 characters, which is short but contains substantive information about legal matters, not just an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2026-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.